Home » AGEB Journal » Issues » Volume 74" » Fasc.3 - Symposium » Article details

Different surgical strategies in the treatment of familial adenomatous polyposis : what's the role of the ileorectal anastomosis ?

Journal Volume 74 - 2011
Issue Fasc.3 - Symposium
Author(s) Albert M. Wolthuis, Daniel Leonard, Alex Kartheuser, Luc Bruyninx, Jean Van De Stadt, Eric Van Cutsem, André D'Hoore
Full article
Full Article
VIEW FREE PDF
(1) Belgian Polyposis Project, Familial Adenomatous Polyposis Association (FAPA), Brussels ; (2) Board Member of the FAPA, Department of Abdominal Surgery, University Hospital Leuven, Leuven ; (3) Board Member of the FAPA, Colorectal Surgery Unit, Department of Abdominal Surgery and Transplantation, Cliniques Universitaires St-Luc, Brussels ; (4) General Secretary of the FAPA, Colorectal Surgery Unit, Department of Abdominal Surgery and Transplantation, Cliniques Universitaires St-Luc, Brussel ; (5) Board Member of the FAPA, Service de Chirurgie digestive, coelioscopique et thoracique, Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels ; (6) Board Member of the FAPA, Clinic of Colorectal Surgery, Department of Digestive Surgery, Hôpital Erasme, Brussels ; (7) President of the FAPA, Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven.

Prophylactic (procto-) colectomy is the treatment of choice to reduce the risk of colorectal cancer in FAP patients with multiple adenomas. Because patients present at young age, rectum-sparing surgery is sometimes advocated, so that there is no pelvic dissection with impact on quality of life, preserved pelvic innervation and sexual function and fertility. The main disadvantage of a total colectomy with an ileorectal anastomosis (IRA) is a rectal cancer risk of 50% at the age of 50 years and a cumulative risk of 25,8% after 25 years of follow-up. Therefore, this procedure should be reserved for patients with an unaffected rectum. There should be no discussion to perform a primary IPAA in patients with multiple rectal adenomas (> 20) or those with a severe dysplastic or large (> 3 cm) rectal adenoma or a cancer elsewhere in the colon. A patient with an IRA should undergo yearly follow-up by recto- scopy. (Acta gastroenterol. belg., 2011, 74, 435-437).

© Acta Gastro-Enterologica Belgica.
PMID 22103050